Portola Pharmaceuticals to Present at Two Upcoming Investor Conferences
05 Juin 2018 - 10:30PM
Portola Pharmaceuticals, Inc.® (Nasdaq:PTLA) today announced that
the company will present at the following conferences in June:
- Goldman Sachs 39th Annual Global Healthcare Conference on
Tuesday, June 12, 2018, at 9:20 a.m. Pacific Time in Rancho Palos
Verdes, CA.
- William Blair 38th Annual Growth Stock Conference on Wednesday,
June 13, 2018, at 12:40 p.m. Central Time in Chicago, IL.
Both presentations will be webcast live and
available for replay from Portola's website at www.portola.com in
the Investor Relations section.
About Portola Pharmaceuticals,
Inc.Portola Pharmaceuticals is a commercial-stage
biopharmaceutical company focused on the discovery, development and
commercialization of novel therapeutics that could significantly
advance the fields of thrombosis and other hematologic diseases.
The Company’s two FDA-approved medicines are Bevyxxa® (betrixaban),
the first and only oral, once-daily Factor Xa inhibitor, and
Andexxa® [coagulation factor Xa (recombinant), inactivated-zhzo],
the first and only antidote for the Factor Xa inhibitors
rivaroxaban and apixaban. The company also is advancing
cerdulatinib, a SYK/JAK inhibitor for the treatment of hematologic
cancers.
Investor
Contact: |
|
|
|
|
|
|
|
|
|
Media
Contact: |
Cara Miller |
|
|
|
|
|
|
|
|
|
Laurie Masonson |
Portola
Pharmaceuticals |
|
|
|
|
|
|
|
|
|
Pure
Communications |
ir@portola.com |
|
|
|
|
|
|
|
|
|
lmasonson@purecommunications.com |
Portola Pharmaceuticals (NASDAQ:PTLA)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Portola Pharmaceuticals (NASDAQ:PTLA)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024
Real-Time news about Portola Pharmaceuticals Inc (NASDAQ): 0 recent articles
Plus d'articles sur